Table: begin end state 1 27 non-cytoplasmic 28 49 transmembrane 50 57 cytoplasmic 58 78 transmembrane 79 89 non-cytoplasmic 90 111 transmembrane 112 127 cytoplasmic 128 150 transmembrane 151 156 non-cytoplasmic 157 176 transmembrane 177 187 cytoplasmic 188 206 transmembrane 207 218 non-cytoplasmic 219 238 transmembrane 239 255 cytoplasmic 256 282 transmembrane 283 301 non-cytoplasmic 302 325 transmembrane 326 350 cytoplasmic 351 373 transmembrane 374 378 non-cytoplasmic 379 398 transmembrane 399 409 cytoplasmic 410 430 transmembrane 431 435 non-cytoplasmic 436 454 transmembrane 455 463 cytoplasmic
Input: >H281DRAFT_02180 FitnessBrowser__Burk376:H281DRAFT_02180 MSLFRKKSVEHMIATSAQNAGLKKALGALDLTFLGVGAIIGTGIFVLTGTGAVQAGPALM VSFLIAAVACGFAALAYAEFASTIPVAGSIYTYSYATLGELAAWIIGWDLMLEYGLATSA VSVGWSGYLQSLLSGFGVSLPVALTAAPGALPGHETLFNLPAFLVMMAITALLSVGVRES ARINNIMVAIKVVVVLLVIAVGVFHVTPANWHPFMPNGWNGVFGAAAVMFFAFIGFDSVS SAAEEVKNPKRDLPIGIIASLGVCAVLYVAVAAVVTGIVPSAQFANISHPVSYALQVAGQ KWVAGFIDLGAVLGMLTVILVMAYGQTRVIFAMSRDGLLPARLSRVHPRFATPFFTTWLV GIFFGLIGALVPLNVLAELINIGTLAAFSMVSIAVLVLRKTHPELPRAFRCPGVPVVPVL AVASCVFLMANLQAVTWVAFVVWLLIGMVIYFGYSRRRSHLAR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server